Clinical Trials Logo

Clinical Trial Summary

During the regular protocol of Intra-tympanic injections of Dexamethasone to the middle ear due to Sudden Sensorineural Hearing Loss, the patients will be sitted once after the injection instead of lying down. They will be then asked to rate their taste as a reference to the amount of fluid leaking to the throat through the eustachian tube.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04449848
Study type Interventional
Source Tel-Aviv Sourasky Medical Center
Contact Yahav Oron, MD
Phone +97236973573
Email oron.yahav@gmail.com
Status Not yet recruiting
Phase N/A
Start date August 1, 2020
Completion date July 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT04601909 - FX-322 in Adults With Age-Related Sensorineural Hearing Loss Phase 1
Completed NCT05086276 - FX-322 in Adults With Acquired Sensorineural Hearing Loss Phase 2
Completed NCT04629664 - FX-322 in Adults With Severe Sensorineural Hearing Loss Phase 1
Completed NCT03747874 - OSA and Sudden Sensorineural Hearing Loss N/A
Recruiting NCT04192656 - The Effect of PAP on ISSHL Comorbided With OSA Phase 4
Not yet recruiting NCT03706183 - Ischemia- Modified Albumin Levels in the Sudden Hearing Loss
Completed NCT03951584 - Prognosis of Vestibular Dysfunction in Patients With Idiopathic Sudden Sensorineural Hearing Loss
Completed NCT04902963 - What is the Tympanic Membrane Healing Time After Insertion of a Gelfoam PE Tube? N/A
Not yet recruiting NCT03974867 - Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids N/A
Not yet recruiting NCT04384640 - The Effect of Patient's Position After Intra-tympanic Injection